Product logins

Find logins to all Clarivate products below.


Despite the impact of the ongoing COVID-19 pandemic, as well as regulatory restrictions surrounding the use of gynecological devices that had been affected by safety-related lawsuits and negative publicity, the Asia Pacific gynecological device market will continue to expand through 2029 due to growing patient awareness of gynecologic treatments in this region. In particular, rising awareness of minimally invasive procedures in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices.

This Medtech 360 Report provides high-level market metrics for gynecological devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Gynecological Devices – Market Insights – Latin America
The Latin American gynecological device market will experience modest growth over the forecast period, driven primarily by increasing awareness of gynecological health and available treatment…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…